Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Published on by Cell Biologist

Prof. Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Macau University of Science and Technology | China

Professor Xinghua (Victor) Pan, PhD, MD, is a distinguished researcher in the fields of single-cell technology, spatial omics, genome medicine, regenerative biology, and cancer heterogeneity. Currently serving as a professor at the Precision Regenerative Medicine Research Centre (PRMRC), Macau University of Science and Technology (MUST), he is also affiliated with the State Key Laboratory of Quality Research in Chinese Medicine. Dr. Pan earned his MD and MS degrees from Southern Medical University and completed his PhD in genetics at Fudan University under the mentorship of renowned geneticist Dr. CC Tan. His interdisciplinary research integrates cutting-edge single-cell and multi-omics platforms to investigate tumor microenvironments, stemness, and disease mechanisms at cellular resolution. Dr. Pan has authored over 280 peer-reviewed publications, with a current h-index of 48, more than 9,200 citations, and his work spans high-impact journals such as Nature, Nature Communications, Advanced Science, Nucleic Acids Research, and Cancer Research. He is frequently recognized as a corresponding or co-corresponding author in key studies advancing genomic technologies and translational applications in precision medicine. His contributions continue to shape the landscape of cellular and molecular research globally.

Profiles: Google Scholar | Orcid

Featured Publications:

Zhang, Y., Lu, Y., Mai, L., Wen, Z., Dai, M., Xu, S., Lin, X., Luo, Y., Qiu, Y., Chen, Y., Dong, Z., Chen, C., Meng, W., Luo, X., Lin, G., Tam, P. K. H., & Pan, X. (2025). Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis. Journal of Advanced Research. Advance online publication.

Su, H., Zhou, X., Lin, G., Luo, C., Meng, W., Lv, C., Chen, Y., Wen, Z., Li, X., Wu, Y., Xiao, C., Yang, J., Lu, J., Luo, X., Hong, X., Chen, Y., Tam, P. K. H., Li, C., Sun, H., & Pan, X. (2025). Deciphering the oncogenic landscape of hepatocytes through integrated single-nucleus and bulk RNA-seq of hepatocellular carcinoma. Advanced Science, 12, e2412944.

Huang, Y., Wang, Q., Zhou, W., Jiang, Y., He, K., Huang, W., Feng, Y., Wu, H., Liu, L., Pan, Y., Huang, Y., Chen, Z., Li, W., Huang, Y., Lin, G., Zhang, Y., Ren, Y., Xu, K., Yu, Y., … Hu, Y. (2024). Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation. Neoplasia, 57, 101054.

Gao, J., Wu, Y., Yu, J., Qiu, Y., Yi, T., Luo, C., Zhang, J., Lu, G., Li, X., Xiong, F., Wu, X., & Pan, X. (2024). Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree. Cancer Medicine, 13(13), e7394.

Chen, F., Zhang, K., Wang, M., He, Z., Yu, B., Wang, X., Pan, X., Luo, Y., Xu, S., Lau, J. T. Y., Han, C., Shi, Y., Sun, Y. E., Li, S., & Hu, Y. P. (2024). VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Advanced Science, 11, e2308711.

Mai, L., Wen, Z., Zhang, Y., Gao, Y., Lin, G., Lian, Z., Yang, X., Zhou, J., Lin, X., Luo, C., Peng, W., Chen, C., Peng, J., Liu, D., Marjani, S. L., Tao, Q., Cui, Y., Zhang, J., Wu, X., Weissman, S. M., & Pan, X. (2023). Shortcut barcoding and early pooling for scalable multiplex single-cell reduced-representation CpG methylation sequencing at single nucleotide resolution. Nucleic Acids Research, 51, e108.

Rachel Foster | Microbial Oceanography | Best Researcher Award

Published on by Cell Biologist

Prof. Rachel Foster | Microbial Oceanography | Best Researcher Award

Stockholm University | Sweden

Rachel A. Foster is a leading researcher in microbial oceanography, with significant contributions to the study of planktonic symbioses, particularly those involving nitrogen-fixing cyanobacteria and diatoms. Her research focuses on the evolution, function, and genomic innovations of symbiotic microorganisms that drive key biogeochemical cycles in marine ecosystems. Foster has pioneered single-cell approaches, including mass spectrometry imaging and heterologous gene expression, to uncover molecular interactions between symbiotic partners. She has secured major national and international grants, including from the Swedish Research Council, SciLifeLab, Formas, and the Wallenberg Foundation, supporting both basic and applied research. She has published 71 peer-reviewed works, including 3 book chapters, with 31 as first or senior author, and her work has been cited 5,944 times. Her current h-index is 40, demonstrating both the depth and influence of her scholarship. Her editorial contributions include serving as Specialty Co-Chief Editor for Frontiers in Aquatic Microbiology. Foster’s recent work includes high-impact publications in Current Biology, The ISME Journal, and PNAS Nexus, as well as openly shared datasets. Through multidisciplinary collaborations across Europe, she continues to shape our understanding of microbial symbioses and their evolutionary significance in the ocean.

Profiles: Scopus | Orcid

Featured Publications:

Grujcic, V., Mehrshad, M., Vigil-Stenman, T., Lundin, D., & Foster, R. A. (2025). Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses. Current Biology.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2025). Retention of a SulP-family bicarbonate transporter in a periplasmic N2-fixing cyanobacterial endosymbiont of an open ocean diatom. The ISME Journal.

Foster, R. A. (2025, April 27). Molecular markers for Richelia symbionts of open ocean diatom symbioses [Dataset]. figshare.

Grujcic, V., Mehrshad, M., Vigil-Stenman, C. T., Lundin, D., & Foster, R. A. (2025, March 25). The path to dependence: Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses [Preprint]. bioRxiv.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2024, January 10). Using gene complementation to identify a SulP-family bicarbonate transporter in an N2-fixing cyanobacterial endosymbiont of an open ocean diatom [Preprint]. bioRxiv.

Nieves-Morión, M., Camargo, S., Bardi, S., Ruiz, M. T., Flores, E., Foster, R. A., & Bayer, E. (2023). Heterologous expression of genes from a cyanobacterial endosymbiont highlights substrate exchanges with its diatom host. PNAS Nexus.

Kelly Bosak | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Kelly Bosak | Stem Cell Research | Best Researcher Award

University of Kansas Medical Center | United States

Dr. Kelly A. Bosak, PhD, APRN, ANP-BC, FHFSA, is a tenured Associate Professor at the University of Kansas Medical Center and a nationally recognized expert in heart failure care, nursing science, and implementation research. With a strong background in advanced practice nursing and nursing administration, Dr. Bosak has made significant contributions to interdisciplinary research focused on improving clinical outcomes in cardiology, rural health, and chronic disease management. Her peer-reviewed work spans high-impact journals such as The Journal of Cardiac Failure, Implementation Science, and The Journal for Nurse Practitioners, reflecting her leadership in both clinical practice and academic scholarship. Dr. Bosak has authored or co-authored over 30 peer-reviewed publications, with a Scopus h-index of 10, over 450 citations, and 32 documents indexed in major databases. She has played a pivotal role in national reports from the Heart Failure Society of America and led multiple implementation science projects aimed at integrating evidence-based interventions into routine care. Her current research emphasizes digital health innovation and workforce development in underserved communities. Dr. Bosak’s interdisciplinary collaborations and translational research continue to shape evidence-based practice and policy in cardiovascular nursing and advanced practice nursing education.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Return on Investment of a Nurse Practitioner Fellowship Program”

  • “Interprofessional Education for Improving Workforce Capacity to Treat COPD and Long COVID in Rural Communities”

  • “Shared Decision Making for the Pulmonary Artery Monitoring Device for Patients with Heart Failure”

  • “Implementation of a SmartPhrase for Exercise in the Electronic Health Record for Individuals with Heart Failure”

  • “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project”

  • “Team Science”

  • “Ceramides as Novel Biomarkers of Cardiometabolic Conditions”

  • “Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America”

  • “Heart Failure Epidemiology and Outcomes Statistics, A Report of the Heart Failure Society of America”

  • “Implementation Mapping and Concept Mapping to Explore Guideline Implementation in the Heart Failure Clinic”

  • “Coordinating Resources for a Hybrid Effectiveness and Implementation Trial Across an Integrated Digital Network for Heart Failure”

  • “Creating a Standardized Approach to Program Evaluation in a Magnet Recognized Pediatric Hospital System”

 

 

 

Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Emine Mine Soylu | Plant Pathology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Emine Mine Soylu | Plant Pathology | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Emine Mine Soylu is a prominent academic in the field of plant pathology, with a career spanning over three decades dedicated to plant protection, host-pathogen interactions, and disease management strategies in crops. She began her professional journey as a Research Assistant at Akdeniz University and has since contributed significantly to scientific research through both experimental studies and scholarly publications. Her work is widely recognized, with a particular focus on the identification and control of fungal and bacterial diseases in economically important plants. Prof. Soylu has published 54 scientific documents in internationally refereed journals and has amassed a total of 3,749 citations, reflecting the substantial impact of her work in the field. Her h-index is 25, indicating consistent and high-quality contributions to science over the years. Her research includes first reports of various plant diseases in Türkiye and in-depth studies on disease resistance mechanisms and biochemical plant responses. Prof. Soylu’s contributions continue to shape the future of sustainable agriculture and plant health, and her collaborations extend across national and international scientific communities. Her scholarly output and citation metrics demonstrate her strong influence in the field of phytopathology and plant-microbe interactions.

Profiles: Google Scholar | Scopus |  Orcid

Featured Publications:

  • “Preliminary Characterization of Race-Specific Elicitors From Peronospora parasitica and Its Ability to Elicit Phenolic Accumulation in Arabidopsis”

  • “First Report of Downy Leaf Spot of Walnuts Caused by Microstroma juglandis in Turkey”

  • “Induction of Disease Resistance by the Plant Activator, Acibenzolar-S-methyl (ASM), Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato Seedlings”

  • “First Report of Powdery Mildew Caused by Erysiphe heraclei on Dill (Anethum graveolens) in Turkey”

  • “Light and Electron Microscopy of the Compatible Interaction Between Arabidopsis and the Downy Mildew Pathogen Peronospora parasitica”

  • “Induction of Defence Related Enzymes and Resistance by the Plant Activator Acibenzolar-S-methyl in Tomato Seedlings Against Bacterial Canker Caused by Clavibacter michiganensis subsp. michiganensis”

  • “First Report of Cercospora Leaf Spot on Swiss Chard Caused by Cercospora beticola in Turkey”

  • “First Report of Phloeospora Leaf Spot on Mulberry Caused by Phloeospora maculans (=Cylindrosporium maculans) in the Eastern Mediterranean Region of Turkey”

  • “Induction of Disease Resistance and Antioxidant Enzymes by Acibenzolar-S-methyl Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato”

  • “First Report of Powdery Mildew Caused by Podosphaera phaseoli (syn. Sphaerotheca phaseoli) on Cowpea (Vigna sinensis) in Turkey”

 

 

 

 

 

 

 

 

 

 

Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Published on by Cell Biologist

Prof. Dr. Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Rowan-Virtua SOM and Virtua Health College of Medicine and Life Sciences of Rowan University | United States

Dr. Paola Leone is a neuroscientist and cell biologist whose work focuses on pediatric white matter diseases, mechanisms of myelination, and gene/cell‐based therapies to repair white matter pathology. After completing a doctoral degree in Neuroscience at the University of Padua (Italy), she undertook a post‑doctoral fellowship in Behavioral Neurobiology at Concordia University, Montreal, where early work included studies on dopamine receptors and opioid interaction in reward pathways. Over subsequent decades, her research has expanded to include using viral vector models, evaluating gene expression in glial and neuronal interactions, and metabolic demands in neurological disease models such as Alzheimer’s and leukodystrophies. According to institutional metrics, her department (Cell Biology at Rowan University) shows ~6,735 citations and an h‑index of 44 across roughly 176 articles (plus reviews and other contributions). Roan University These figures reflect both leadership in publications and influence in the neuroscience/cell biology community. Her scholarly contributions have significantly advanced understanding of neuron‑glia energetics, genetic regulation of myelination, and translational strategies for repair in white matter disease.

Profile: Scopus

Featured Publications:

  • “Blockade of D1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning”

  • “5HT3 receptor antagonists block morphine and nicotine- but not amphetamine-induced reward”

  • “SCH 23390 blocks drug-conditioned place preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?”

  • “Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release as measured by in vivo microdialysis”

  • “Intrahippocampal injection of a HSV-1 vector expressing GluR6 induces spontaneous limbic seizures and CA1 and CA3 hyperexcitability”

  • “Differential involvement of ventral tegmental Mu, Delta and Kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies”

  • “Ventral mesencephalic & opioid are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study”

  • “Striatal tissue preparation facilitates early sampling in microdialysis and reveals an index of neuronal damage”

  • “Mesolimbic dopamine neurotransmission is increased by administration of µ-opioid receptor antagonists”

  • “Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures”

Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Aligarh Muslim University | India

Dr. Rizwan Hasan Khan is a distinguished professor at the Interdisciplinary Biotechnology Unit of Aligarh Muslim University, specializing in biophysical chemistry and molecular interactions related to protein aggregation and therapeutic drug design. With a Ph.D. awarded focused on lectins, Dr. Khan has significantly contributed to understanding protein fibrillation, aggregation mechanisms, and their inhibition, particularly in relation to amyloid diseases and antimicrobial resistance. His research encompasses the biophysical characterization of proteins, the impact of toxins and drugs on protein behavior, and the identification of novel inhibitors through computational and experimental approaches. Dr. Khan’s prolific output includes over 16 peer-reviewed research and review articles published in reputed journals such as Biophysical Chemistry, Archives of Biochemistry and Biophysics, and Cell Reports, reflecting interdisciplinary expertise in biotechnology, biochemistry, and drug discovery. His work has attracted citations highlighting its influence in the fields of amyloid research and therapeutic development. Dr. Khan maintains an h-index indicative of sustained scholarly impact, underscoring his role as a leading researcher in molecular biophysics and pharmacology. His research continues to advance knowledge in combating protein aggregation disorders and antimicrobial resistance, contributing valuable insights into novel drug candidates and molecular mechanisms.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu (II) flufenamate chemotherapeutic drug candidate”

  • “Ponceau 4R induces aggregation in human serum albumin and morin acts as an anti-aggregating agent against dye induced aggregates”

  • “Hippuric acid, a uremic toxin, binds to aggregation prone region of human lysozyme and potentiates the fibrillation: A biophysical insight”

  • “Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics”

  • “Loss of Neurofibromin Induces Inflammatory Macrophage Phenotypic Switch and Retinal Neovascularization via GLUT1 Activation”

  • “Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin”

  • “Interaction of Esculetin with Alpha-2-Macroglobulin: Biochemical and Biophysical Approaches”

  • “Utilizing non-β-lactam antibiotics to combat antimicrobial resistance by targeting multiple virulence factors of Pseudomonas aeruginosa”

  • “Strategies for inhibiting amyloid fibrillation: Current status and future prospects”

  • “Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies”

Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Research Center for Eco-Environmental Sciences | China

Bao-Min Yao is a distinguished researcher affiliated with multiple prestigious institutions, including the School of Environmental & Resource Sciences at Shanxi University, the State Key Laboratory of Urban and Regional Ecology at the Research Center for Eco-Environmental Sciences of the Chinese Academy of Sciences, the University of Chinese Academy of Sciences, the School of Life Sciences at Hebei University, and the Municipal Engineering Department at Beijing University of Technology. His interdisciplinary work spans environmental science, urban ecology, and civil engineering, reflecting a comprehensive approach to addressing complex ecological and environmental challenges. Over the course of his career, Bao-Min Yao has authored a substantial number of scientific publications, contributing significantly to the advancement of knowledge in his fields of expertise. His research output has been widely recognized, as evidenced by a strong citation record and a notable h-index, indicating both the productivity and the impact of his work within the scientific community. His contributions encompass studies on ecological sustainability, resource management, and environmental protection, underpinning policy and technological innovation. Bao-Min Yao’s dedication to research excellence is further demonstrated through his collaborative engagements across institutions, fostering interdisciplinary dialogues and innovations. His scholarly influence is reflected in the volume of citations his work has garnered, underscoring his role as a leading voice in environmental and ecological research.

Profile: Scopus

Featured Publications:

“Soil pH and bacterial diversity synergistically regulate trace element transfer and accumulation in soil-rice systems”

Maria Antonietta Grignano | Cellular Stress Response | Best Researcher Award

Published on by Cell Biologist

Dr. Maria Antonietta Grignano | Cellular Stress Response | Best Researcher Award

Fondazione IRCCS Policlinico San Matteo di Pavia | Italy

Dr. Maria Antonietta Grignano is a biologist and specialist in clinical pathology and biochemistry, currently serving as a researcher and head of the Research Laboratory of the Nephrology, Dialysis, and Transplantation Unit at Fondazione IRCCS Policlinico San Matteo. Her research has focused on innovative strategies in kidney transplantation, ischemia-reperfusion injury, and the use of mesenchymal stromal cell-derived extracellular vesicles for organ conditioning. She has contributed to both preclinical and translational studies, with a particular emphasis on engineered vesicles and molecular profiling in transplant immunology. Dr. Grignano has authored over 30 scientific publications indexed in Scopus and Web of Science, contributing to high-impact journals such as the International Journal of Molecular Sciences, Blood Purification, and Transplant International. Her work includes collaborations with national institutions like the University of Pavia and international partners including Columbia University and universities in the Netherlands. As a recognized reviewer for several peer-reviewed journals, she maintains a strong presence in academic publishing. According to Scopus, she has an h-index of 8 with 162 total citations, and 9 citations indexed in Web of Science, reflecting the growing recognition of her work in nephrology and transplant science. Her scientific contributions span experimental design, data analysis, and dissemination of findings.

Profiles: Scopus | Orcid

Featured Publications:

  • “A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model”

  • “Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model”

  • “Pre-transplant IE1-specific T-cell response and CD8 + T-cell count as predictive markers of treated HCMV reactivation in kidney transplant recipients”

  • “Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review”

  • “The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis”

  • “Sputum proteomics in lung disorders”

  • “Induction of Vesicular Trafficking and JNK-Mediated Apoptotic Signaling in Mononuclear Leukocytes Marks the Immuno-Proteostasis Response to Uremic Proteins”

  • “CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death”

  • “SARS-CoV-2-specific IgG and NCP in vulnerable patients without symptoms”

  • “Liposome Formulation and In Vitro Testing in Non-Physiological Conditions Addressed to Ex Vivo Kidney Perfusion”

 

 

Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Published on by Cell Biologist

Dr. Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Kfshrc | Saudi Arabia

Dr. Ali Alahmari is a distinguished consultant in Acute Leukemia, Hematology, Hematopoietic Stem Cell Transplantation (HSCT), and Cellular Therapy at King Faisal Specialist Hospital & Research Centre. He earned his MBBS degree from King Saud University and completed his internship at King Khalid University Hospital. He has held a key consultant position, contributing extensively to the advancement of cellular therapy and bone marrow transplantation in Saudi Arabia. Dr. Alahmari has made significant academic contributions to the field, particularly in hemato-hepatology and sickle cell disease. His research has focused on novel transplant approaches, including haploidentical stem cell transplantation after liver transplantation and donor impact in severe aplastic anemia. He has co-authored over 22 scientific documents, with his work accumulating more than 629 citations and earning an h-index of 12, reflecting the depth and influence of his research. His notable publications include titles such as “Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia“ and “Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction.” Dr. Alahmari’s ongoing efforts continue to shape clinical best practices and research frameworks for hematologic disorders and transplantation medicine in the region.

Profile: Scopus

Featured Publications:

  • “Author Correction: Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT”

  • “Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia”

  • “Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Hematopoietic Stem Cell Transplantation in Sickle Cell Disease”

  • “Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation”

  • “Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience”